Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
N6-methyladenosine (m6A) is a widespread modification on cellular RNA that is dynamically regulated involving m6A writers, erasers and readers, and can impact many cellular processes and pathways. A recent study demonstrates that viruses can use m6A to ensure their RNA avoids innate immune sensing.
Two studies now identify bradyzoite-formation deficient 1 and microrchidia as ‘master regulators’ of the transcriptional events that control developmental life cycle transitions in the protozoan parasite Toxoplasma gondii.
Resistance to antibiotics is a hot topic in microbiology, but there is much less coverage on resistance to vaccines. The associated risk to disease control has potentially devastating implications, but advances are being made towards smarter vaccine design that reduces the risk of antibiotic-resistant disease.
Bacteriophage therapeutics has emerged as one of the few potential beacons that represent possible solutions to the growing global crisis of antimicrobial resistance. Bringing science to the bedside (and vice versa) will maximize the potential of this compelling opportunity.
Mosquitoes have been known for over a century to transmit viruses such as yellow fever. However, laboratory studies to identify the species capable of natural transmission still fail to explain some outbreaks, such as Zika. Now, this paradox is partially explained by a simple methodological shortcoming.
Antibiotic overuse has led to a rise of multidrug-resistant pathogens and increased morbidity. A new study shows that the microbiome can prime two different host response pathways in the intestine and lungs that protect against an antibiotic-resistant pathogen.
